Forschungszentrum für Immuntherapie (FZI)
Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz
Luebke, Johannes; Christen, Deborah; Schwaab, Juliana et al.
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registriesLEUKEMIA. 2024
Boesl, Fabian; Goereci, Yasemin; Schweitzer, Finja et al.
Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damageSCIENTIFIC REPORTS. Bd. 14. H. 1. 2024
Ritter, Katharina; Somnuke, Pawit; Hu, Lingjiao et al.
Current state of neuroprotective therapy using antibiotics in human traumatic brain injury and animal modelsBMC NEUROSCIENCE. Bd. 25. H. 1. 2024
Salwender, Hans; Weinhold, Niels; Benner, Axel et al.
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trialHEMATOLOGY. Bd. 29. H. 1. 2024
Caenepeel, Clara; Falony, Gwen; Machiels, Kathleen et al.
Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel DiseaseGASTROENTEROLOGY. Bd. 166. H. 3. 2024 S. 483-495
Mikulicic, Snjezana; Shamun, Merha; Massenberg, Annika et al.
ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activityFRONTIERS IN IMMUNOLOGY. Bd. 15. 2024
Deleu, S.; Caenepeel, C.; Castellanos, J. F. Vazquez et al.
Faecal microbiota transplantation in active Ulcerative Colitis: Key lessons from a randomized controlled trial halted for futilityJOURNAL OF CROHNS & COLITIS. Bd. 18. 2024 S. I158-I159
Lang, Franziska; Schroers, Barbara; Loewer, Martin et al.
Identification of neoantigens for individualized therapeutic cancer vaccines (vol 21, pg 261, 2022)NATURE REVIEWS DRUG DISCOVERY. Bd. 23. H. 2. 2024 S. 156-156
Dhillon-LaBrooy, Ayesha; Braband, Kathrin L.; Tantawy, Eshraq et al.
Inhibition of Mitochondrial Translation Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation by Targeting Vy4D y8 T CellsJOURNAL OF INVESTIGATIVE DERMATOLOGY. Bd. 144. H. 4. 2024
Leypoldt, Lisa B.; Tichy, Diana; Besemer, Britta et al.
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple MyelomaJOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 1. 2024 S. 26-+